Results 171 to 180 of about 6,221,821 (301)

14-day Empirical Therapy Compared with 7-day Tailored Therapy for <i>Helicobacter pylori</i> Eradication in Korea: Results of the K-CREATE Phase II Study. [PDF]

Yonsei Med J
Kim JS, Kim BW, Chung WC, Jung SW, Kim JI, Kim GH, Park SY, Jeon SW, Joo MK, Kim TH, Choi CW.   +10 more
europepmc   +1 more source

Modular Control of PEG‐Poly(2‐Oxazoline) Co‐Assembly Enables Tunable Aggregate Properties for Intraocular Pressure Management

Advanced Healthcare Materials, EarlyView.
A thermo‐responsive poly(2‐oxazoline)‐based injectable formulation is developed to modulate intraocular pressure (IOP) in both normal and hypotonic eyes. By adjusting the PEG content, the aggregation behavior is finely tuned, enabling IOP elevation without long‐term deposition.
Yuji Tanaka, Shohei Morikawa, Shigehito Osawa   +2 more
wiley   +1 more source

Personalised management of community-acquired pneumonia and the role of Clinical Decision Support Software. [PDF]

BMJ Open Respir Res
Hatton C, Atkin C, Gallier S, Sapey E.
europepmc   +1 more source

ETV2 Mediated Differentiation of Human Pluripotent Stem Cells Results in Functional Endothelial Cells for Engineering Advanced Vascularized Microphysiological Models

Advanced Healthcare Materials, EarlyView.
A robust method to generate functional human iPSC‐derived endothelial cells using inducible ETV2 expression. These cells self‐organize into stable, lumenized microvascular networks within microfluidic chips, surpassing conventional differentiation methods.
Shun Zhang, Zhengpeng Wan, Lei Wang, Caihong Wu, Junkai Zhang, Sarah Spitz, Xun Wang, Marie A. Floryan, Mark F. Coughlin, Francesca M. Pramotton, Liling Xu, Ron Weiss, Roger D. Kamm   +12 more
wiley   +1 more source

Assessment of segregation variance estimates from derivation, simulations, and empirical data in autotetraploid species exemplified in potato. [PDF]

Genetics
Wu PY, Thelen K, Hartje S, Muders K, Prigge V, Stich B, Van Inghelandt D.   +6 more
europepmc   +1 more source

Development of a Synthetic Hydrogel to Foster Microvascularization of an Endometriosis Microphysiological System

Advanced Healthcare Materials, EarlyView.
ABSTRACT The ascent of novel alternative methods in drug development spotlights the dual needs for improved biological fidelity to in vivo, along with reproducibility, especially in regulatory applications. The need for pre‐clinical models of patient‐derived endometriosis lesions motivates the development of a vascularizable, completely synthetic ...
Lauren Pruett, Laura Bahlmann, Ryan Ogi, Angela Jiao, Priyatanu Roy, Matthew Johnson, David Trumper, Linda Griffith   +7 more
wiley   +1 more source

Susceptibility-Guided Versus Empirical First-Line Therapy of Helicobacter pylori Infection in Adults: A Systematic Review and Meta-Analysis. [PDF]

Helicobacter
Rocha MC, Gaspar T, Bernardes C, Nunes PP.   +3 more
europepmc   +1 more source

Wound Geometry Determines Whether Aligned‐Fiber Scaffolds Accelerate or Impede Diabetic Wound Healing: A Biased Random Walk Analysis

Advanced Healthcare Materials, EarlyView.
Wound closure is governed by geometry‐orientation coupling: aligned fibers speed migration along their axis but hinder perpendicular advance. In vivo diabetic wound experiments with composition‐matched fibrin, combined with an anisotropic diffusion (biased random‐walk) model, quantify this trade‐off and generate a healing landscape.
Yin‐Yuan Huang, Xiangjun Peng, Yuxuan Huang, Kunkoo Kim, Chengli Li, Peilun Hu, Sean J. Wang, Rohan Avula, Chun‐Yi Yang, Pengchao Ma, Shuhui Yang, Shumeng Jiang, Guy M. Genin, Xiumei Wang   +13 more
wiley   +1 more source

Mortality risk of ESBL producers in Escherichia coli bacteraemia: a comprehensive analysis using the PROBAC cohort. [PDF]

J Antimicrob Chemother
Olivares-Navarro P, Pérez-Rodríguez MT, Sousa A, Goikoetxea-Agirre AJ, Blanco Vidal MJ, Plata A, León E, Buzón-Martín L, Pulido-Navazo Á, Boix-Palop L, Retamar-Gentil P, Armiñanzas-Castillo C, Fernández-Natal I, Del Arco Jiménez A, Jover-Sáenz A, Fernández-Suárez J, Martín-Aspas A, Smithson-Amat A, Bahamonde-Carrasco A, Natera-Kindelán C, Martínez Pérez-Crespo PM, López-Hernández I, Rodríguez-Baño J, López-Cortés LE, PROBAC/GEIRAS-SEIMC/SAMICEI .   +24 more
europepmc   +1 more source

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

Advanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang, Jingguo Qu, Tonghuan Xiao, Xinyang Han, Michael Tin‐Cheung Ying   +4 more
wiley   +1 more source